Edwin M. Kania Jr.

Edwin M. Kania Jr., listed as board member, has filed trades across 6 companies (mainly through SEC (Form 4)), most often in Acceleron Pharma Inc, TransMedics Group, Inc. and BG Medicine, Inc. In total, 74 filings cover trades dated from 21 July 2006 to 22 May 2025.

The open-market side counts 3 purchases for €2.5M alongside 20 sales for €45.4M. Taken together, the sales exceed the purchases by €42.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 8 share grants.

The median purchase comes to €509k. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -18.9%. These figures describe past trades and do not predict future prices.

The latest filing, published on 23 May 2025, reports a share grant in TransMedics Group, Inc. The latest purchase dates back some time: it was published 1,804 days ago, on 30 November 2021. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.